2017
DOI: 10.5114/kitp.2017.72226
|View full text |Cite
|
Sign up to set email alerts
|

Prometheus therapy for the treatment of acute liver failure in patients after cardiac surgery

Abstract: IntroductionAcute liver failure usually develops in multiple organ dysfunction syndrome and significantly increases the mortality risk in patients after cardiac surgery.AimTo assess the safety and efficacy of extracorporeal liver support in patients with acute liver failure after cardiac surgery.Material and methodsWe studied 39 adult patients with multiple organ dysfunction syndrome and acute liver failure as postoperative complication, treated with Prometheus therapy. Inclusion criteria comprised clinical an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
21
0
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(30 citation statements)
references
References 23 publications
2
21
0
3
Order By: Relevance
“…In the same centre, we reported 15.6% and 13.6% SSI prevalence rates in 2013 and 2014 studies, respectively [ 18 ]. This is comparable to high incidences of SSIs reported across Nigeria [ 19 , 20 , 21 , 22 , 23 ], Ethiopia (19.1%) [ 24 ] and Tanzania (26.0%) [ 25 ]. It was however, higher than figures reported in Egypt [ 26 ], Ghana [ 27 ], England [ 28 ] and USA [ 29 ].…”
Section: Discussionsupporting
confidence: 76%
“…In the same centre, we reported 15.6% and 13.6% SSI prevalence rates in 2013 and 2014 studies, respectively [ 18 ]. This is comparable to high incidences of SSIs reported across Nigeria [ 19 , 20 , 21 , 22 , 23 ], Ethiopia (19.1%) [ 24 ] and Tanzania (26.0%) [ 25 ]. It was however, higher than figures reported in Egypt [ 26 ], Ghana [ 27 ], England [ 28 ] and USA [ 29 ].…”
Section: Discussionsupporting
confidence: 76%
“…In previous studies, older age had been identi ed as an independent risk factor of mortality for patients with hyperbilirubinemia after cardiac surgery. [30] In our present study, older age was established a risk factor for in-hospital mortality for patients with hyperbilirubinemia after AAD surgery as well. Aging indicated diminished functional capacity of the liver and added to the cumulative burden in the case of developed severe hyperbilirubinemia.…”
Section: 3risk Factors Of In-hospital and Long-term Mortalitymentioning
confidence: 59%
“…Furthermore, identifying and implementing effective risk reduction strategies is needed. Molecular adsorbent recirculation system, prometheus therapy, fractionated plasma separation and adsorption have shown promise in reducing bilirubin concentration, [30,34] but the ideal timing of blood puri cation initiation after cardiac surgery remains uncertain and further study in this area is needed.…”
Section: 3risk Factors Of In-hospital and Long-term Mortalitymentioning
confidence: 99%
“…Molecular adsorbent recirculation system, Fig. 3 Long-term survival results of (a) all patients, b patients without AKI and those with stage 1, 2, or 3 AKI, c patients without the use of CRRT and those with CRRT, d patients without the use of ECMO and those with ECMO, e patients with post-operation peak TB ≥ 121.2 μmol/l and those with post-operation peak TB < 121.2 μmol/l prometheus therapy, fractionated plasma separation and adsorption have shown promise in reducing bilirubin concentration [30,34], but the ideal timing of blood purification initiation after cardiac surgery remains uncertain and further study in this area is needed.…”
Section: Risk Factors Of In-hospital and Long-term Mortalitymentioning
confidence: 99%